The Food and Drug Administration approved CombinatoRx Inc.'s (Nasdaq: CRXX) extended release opioid pain treatment Exalgo sending the stock price soaring 39 cents to $1.50.
FDA Approves CombinatoRx's Exalgo
March 02, 2010 at 12:47 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.